BMS986168

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
5	進行性核上性麻痺	2

5. 進行性核上性麻痺

臨床試験数 : 89 / 薬物数 : 107 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-002554-21-ES (EUCTR)	08/06/2017	24/04/2017	A study to test the effectiveness and safety of test product BMS-986168 compared to placebo in parti ...	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Sa ...	Progressive supranuclear palsy MedDRA version: 19.1;Level: PT;Classification code 10036813;Term: Pro ...	Product Code: BMS-986168 INN or Proposed INN: BMS986168 Other descriptive name: BMS986168	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting			Female: yes Male: yes	396	Phase 2	United States;Greece;Spain;Austria;Russian Federation;Italy;United Kingdom;France;Canada;Australia;G ...
2	EUCTR2016-002554-21-FR (EUCTR)		15/06/2018	A study to test the effectiveness and safety of test product BMS-986168 compared to placebo in parti ...	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Sa ...	Progressive supranuclear palsy MedDRA version: 20.0;Level: PT;Classification code 10036813;Term: Pro ...	Product Code: BMS-986168 INN or Proposed INN: BMS986168 Other descriptive name: BMS986168	Bristol-Myers Squibb International Corporation	NULL	NA			Female: yes Male: yes	396	Phase 2	United States;Greece;Spain;Austria;Russian Federation;United Kingdom;Italy;France;Canada;Australia;G ...

First Previous1Next Last